A phase 2 study of Evinacumab in severe hypertriglyceridemia.
Phase of Trial: Phase II
Latest Information Update: 14 Feb 2018
At a glance
- Drugs Evinacumab (Primary)
- Indications Hypertriglyceridaemia
- Focus Therapeutic Use
- 14 Feb 2018 New trial record
- 08 Feb 2018 According to a Regeneron Pharmaceuticals media release, company plans to initiate the trial in 2018.